Sorrento Therapeutics
SRNEQ
#10205
Rank
A$24.49 M
Marketcap
A$0.04443
Share price
3.45%
Change (1 day)
-92.08%
Change (1 year)

Sorrento Therapeutics (SRNEQ) - Net assets

Net assets on the balance sheet as of June 2023 : -A$0.3 Billion

According to Sorrento Therapeutics 's latest financial reports the company has -A$0.3 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Sorrento Therapeutics - Net assets on balance sheet (from 2004 to 2023)

Net assets by year

Year Net assets Change
2022-12-31$-A$31.85 Million-129.55%
2021-12-31$A$0.10 B-41.12%
2020-12-31$A$0.18 B291.2%
2019-12-31$A$46.78 M-84.12%
2018-12-31$A$0.29 B11.3%
2017-12-31$A$0.26 B120.53%
2016-12-31$A$0.12 B-37.97%
2015-12-31$A$0.19 B45.64%
2014-12-31$A$0.13 B77.35%
2013-12-31$A$74.89 M1155.93%
2012-12-31$A$5.96 M45.26%
2011-12-31$A$4.1 M-17.97%
2010-12-31$A$5 M40.47%
2009-12-31$A$3.56 M-2240.35%
2008-12-31$-A$0.17 Million-882.74%
2007-12-31$A$0.02 M-103.55%
2006-12-31$-A$0.6 Million1247.42%
2005-12-31$-A$0.05 Million-89.91%
2004-12-31$-A$0.45 Million-3.73%
2003-12-31$-A$0.46 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Karyopharm Therapeutics
KPTI
-A$0.4 Billion 36.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$3.20 B-1,191.51%๐Ÿ‡บ๐Ÿ‡ธ USA